Placebo comparator: single intravenous (IV) dose of placebo to match sarilumab administration  II, III  Primary: time to resolution of fever for at least 48 hr without antipyretics for 48 hr (Up to Day 29), percentage of patients reporting each severity rating on a 6‐point ordinal scale (Day 15)